Ravuconazole
Encyclopedia
Ravuconazole is a potent triazole
antifungal, being developed by Bristol-Myers Squibb
, that is currently in phase I/II clinical trials. . The drug has a shown to have a similar spectrum of activity to voriconazole
, with an increased half-life. However, ravuconazole has limited activity against species of fusarium, scedosporium and zygomycetes.
Triazole
Triazole refers to either one of a pair of isomeric chemical compounds with molecular formula C2H3N3, having a five-membered ring of two carbon atoms and three nitrogen atoms.The two isomers are:*1,2,3-Triazole 100px*1,2,4-Triazole 100px...
antifungal, being developed by Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb , often referred to as BMS, is a pharmaceutical company, headquartered in New York City. The company was formed in 1989, following the merger of its predecessors Bristol-Myers and the Squibb Corporation...
, that is currently in phase I/II clinical trials. . The drug has a shown to have a similar spectrum of activity to voriconazole
Voriconazole
Voriconazole is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.-Invasive...
, with an increased half-life. However, ravuconazole has limited activity against species of fusarium, scedosporium and zygomycetes.